Drew Armstrong
banner
drewsnews.bsky.social
Drew Armstrong
@drewsnews.bsky.social
Endpoints News executive editor -- where the business of medicine gets answers. Posts on biotech, pharma, drugs, financial markets science and business (and how they all intersect). #biosky

Priors: Bloomberg News + the Covid vaccine tracker. CQ.
See you in a few minutes!
July 29, 2025 at 4:52 PM
Reposted by Drew Armstrong
🎙️ Today on Endpoints News Post-Hoc Live, we're talking about Sarepta. @drewsnews.bsky.social will be joined at 1:30pm ET by @jaredwhitlock.bsky.social and @leileiwu.bsky.social about the company's showdown with the FDA over its #duchennegenetherapy. Watch live here: endpoints.news/endpoints-li...
Live at 1:30 p.m. ET: What happens next with Sarepta and its showdown with the FDA?
Sarepta Therapeutics faces layoffs, reports third patient death, and FDA conflict over Duchenne gene therapy; reporters to discuss developments in live session.
endpoints.news
July 21, 2025 at 3:23 PM
Reposted by Drew Armstrong
Join us at 1130am ET today for our latest Post-Hoc Live stream, to talk about Trump's "most favored nation" drug price plan. Executive editor @drewsnews.bsky.social and Nick Shipley talk about how the executive order works (or doesn't) and what happens next. www.youtube.com/live/7qGP5Ge...
"Most Favored Nation": The White House plan to cut drug prices
YouTube video by Endpoints News
www.youtube.com
May 13, 2025 at 1:09 PM
I've been trying to do this chat for YEARS and am so glad we are finally making it happen. Come for the health policy, stay for the GameStop story.
If you are going to the FT Pharma and Biotech summit on Thursday, please come drop by my session where I'll be chatting with @drewsnews.bsky.social about my lil cancer, and some other fun things. uspharma.live.ft.com/agenda
May 13, 2025 at 7:04 PM
Reposted by Drew Armstrong
If you are going to the FT Pharma and Biotech summit on Thursday, please come drop by my session where I'll be chatting with @drewsnews.bsky.social about my lil cancer, and some other fun things. uspharma.live.ft.com/agenda
May 13, 2025 at 4:44 PM
Reposted by Drew Armstrong
Elon Musk said DOGE made a mistake by cutting USAID’s Ebola prevention but it had been “restored.”

That’s not true, current and former officials told me and @johnphudson.bsky.social.

“There have been no efforts to ‘turn on’” Ebola prevention, said Nidhi Bouri, who oversaw team until January.
Musk claims DOGE ‘restored’ Ebola prevention effort. Officials disagree.
USAID’s initiatives to fight Ebola and other diseases have been gutted, current and former agency officials said.
www.washingtonpost.com
February 26, 2025 at 11:41 PM
Reposted by Drew Armstrong
Kudos to the @endpts.com team for not running away from this issue like everyone else.
February 27, 2025 at 6:21 PM
Reposted by Drew Armstrong
Exclusive: Drugmakers plan Trump meeting next week amid Washington health shakeups, via @drewsnews.bsky.social

endpts.com/drugmakers-p...
Exclusive: Drugmakers plan Trump meeting next week amid Washington health shakeups
Major drugmakers are planning to meet with President Donald Trump next week at the White House as part of the industry’s effort to work with the new administration.
endpts.com
February 14, 2025 at 7:26 PM
Reposted by Drew Armstrong
Well, as I said a couple of weeks ago, thank God I'm not a CEO and I don't have to do this sort of dirty work. Because let's not kid around: if it has to do with the intersection of business and the Trump administration as it's been running so far, it's going to end up being dirty.
Exclusive: Drugmakers plan Trump meeting next week amid Washington health shakeups
Major drugmakers are planning to meet with President Donald Trump next week at the White House as part of the industry’s effort to work with the new administration.
endpts.com
February 14, 2025 at 7:38 PM
Kennedy made promises that he'll be a moderate on vaccines, and then Trump blew them up.

endpts.com/trump-underc...
We’re about to find out which RFK will show up at HHS
Robert F. Kennedy Jr. advances toward Senate confirmation despite vaccine controversy, as key skeptic Sen. Bill Cassidy backs nomination after receiving
endpts.com
February 4, 2025 at 5:34 PM
🏈📺This Hims Super Bowl ad leans very hard into the "pharma bad" / MAHA angle.

Looks like these guy are picking a fight (in part over compounding, but swinging bigger than that) with pharma:

www.youtube.com/watch?v=l5l6...
https://www.youtube.com/watch?v=l5l6QMNnqoc
t.co
January 28, 2025 at 3:19 PM
We're a week out from Endpoints News at #JPM2025, and the agenda is fantastic!

We'll talk through the Trump transition, AI's year ahead, John Carrol will lead chats on cancer and dealmaking, and more.

If you don't have a ticket, I've got a discount 😉> JPM25_10

events.endpts.com/jpm25/697639...
Endpoints at #JPM25 - January 13-14, 2025 - San Francisco
In the biopharma world, the new year doesn’t start on January 1 — it starts when the industry descends on San Francisco for JPM.
events.endpts.com
January 6, 2025 at 4:34 PM
Reposted by Drew Armstrong
Tirzepatide shortage is over, says FDA. That means compounding pharmacies making lots of copies of brand-name Zepbound and Mounjaro have to stop soon.

endpts.com/in-blow-to-c...
In blow to compounders, FDA reaffirms tirzepatide shortage is over
The FDA has reaffirmed that the shortage of Eli Lilly’s blockbuster obesity and diabetes medications is resolved, dealing a blow to pharmacies and telehealth services that have capitalized on providin...
endpts.com
December 19, 2024 at 3:48 PM
⬆️⬇️ It's here! Biopharma's winners, losers, featuring a 🐴

endpts.com/endpoints-wi...
The Endpoints 2024 winners and losers list: Who was up and who was down in biopharma
Endpoints News reviews 2024's biopharma winners & losers: Eli Lilly dominates obesity market, megadeals decline, I&I sector thrives, and FDA's setback in misinformation fight.
endpts.com
December 19, 2024 at 2:36 PM
...Pain trials are hard (so is anything w/ patient self-scoring)

...And placebo problems are real

...But this is a result that could kill a program or even a company at little biotech. (Vertex has the $$ + rep for Ph3 to find out if they're right.)

endpts.com/vertexs-non-...
Vertex’s non-opioid pill disappoints in mid-stage chronic pain study
Vertex Pharmaceuticals announced highly anticipated results from a Phase 2 trial Thursday morning in a chronic pain condition, saying its non-opioid pain pill suzetrigine met the primary endpoint and ...
endpts.com
December 19, 2024 at 1:49 PM
The @endpts.com JPM agenda is LIVE. This is going to be next-level. We've got Jennifer Doudna, Scott Gottlieb, Hal Barron, Eric Tokat, Janet Woodcock, Steve Hahn and many, MANY more huge names...

events.endpts.com/jpm25/agenda
Agenda
events.endpts.com
December 18, 2024 at 3:57 PM
Reposted by Drew Armstrong
If you're an @endpts.com subscriber, you may have recently seen a note in your inbox from @drewsnews.bsky.social. The TLDR is that many of us are here, on this site, giving you the biopharma and health care news you need. Give us a follow! Give us feedback! I always want to hear how we can improve.
December 17, 2024 at 7:55 PM
Reposted by Drew Armstrong
Just finding us here? Endpoints News has a starter pack with our journalists so you can follow the team!
go.bsky.app/NzDRUhL
December 17, 2024 at 7:38 PM
I wrote about covering a shooting a 13 years ago, how the medium of the moment distorts violence in strange ways, and the strange, worrying moment we're in with the killing of an insurance executive.

endpts.com/post-hoc-wha...
December 11, 2024 at 5:36 PM
Reposted by Drew Armstrong
Scoop with @kylelahucik.bsky.social and @drewsnews.bsky.social: There's a changing of the guards atop a16z's health and biotech team. Vijay Pande is handing over the reins to Vineeta Agarwala as he prepares for a larger role involving AI in healthcare. endpts.com/vijay-pande-...
Exclusive: Vijay Pande hands a16z biotech leadership to Vineeta Agarwala, moves to AI role
The biotech and life sciences team at a16z is getting a new leader, as founding investor Vijay Pande moves into a role focused on artificial intelligence and its healthcare applications, Endpoints New...
endpts.com
December 9, 2024 at 6:56 PM
A great follow on rare disease, diagnostics and cool tech:
December 4, 2024 at 8:59 PM
UnitedHealth has confirmed the shooting and death of insurance group head Brian Thompson in Manhattan this morning. They've (obviously) canceled investor day. Completely shocking.

endpts.com/ceo-of-unite...
CEO of UnitedHealth insurance unit shot and killed in New York
UnitedHealthcare CEO Brian Thompson was shot and killed in Midtown Manhattan on Wednesday morning, according to media reports.
endpts.com
December 4, 2024 at 2:44 PM
OMG -- $UNH exec Brian Thompson (leads insurance business) shot and killed in Manhattan, the Post is reporting. Citing police saying it may have been a targeted attack. Totally shocking.

nypost.com/2024/12/04/u...
Exclusive | UnitedHealthcare CEO fatally shot outside of Hilton hotel in Midtown in possible targeted attack: sources
The CEO of UnitedHealth was fatally shot in the chest Wednesday morning outside the Hilton hotel in Midtown in what police say was a targeted attack.
nypost.com
December 4, 2024 at 2:05 PM